These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 20615624)
1. Tumor volume and metabolism of prostate cancer determined by proton magnetic resonance spectroscopic imaging at 3T without endorectal coil reveal potential clinical implications in the context of radiation oncology. Créhange G; Parfait S; Liegard M; Maingon P; Ben Salem D; Cochet A; Funes de la Vega M; Cormier L; Bonnetain F; Mirjolet C; Brunotte F; Walker PM Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1087-94. PubMed ID: 20615624 [TBL] [Abstract][Full Text] [Related]
2. 1H-MRSI of prostate cancer: the relationship between metabolite ratio and tumor proliferation. Wang XZ; Wang B; Gao ZQ; Liu JG; Liu ZQ; Niu QL; Sun ZK; Yuan YX Eur J Radiol; 2010 Feb; 73(2):345-51. PubMed ID: 19070978 [TBL] [Abstract][Full Text] [Related]
3. Reduced power magnetic resonance spectroscopic imaging of the prostate at 4.0 Tesla. Near J; Romagnoli C; Bartha R Magn Reson Med; 2009 Feb; 61(2):273-81. PubMed ID: 19165876 [TBL] [Abstract][Full Text] [Related]
4. 3D MR-spectroscopic imaging assessment of metabolic activity in the prostate during the PSA "bounce" following 125iodine brachytherapy. Kirilova A; Damyanovich A; Crook J; Jezioranski J; Wallace K; Pintilie M Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):371-8. PubMed ID: 20421147 [TBL] [Abstract][Full Text] [Related]
5. (31) P MR spectroscopic imaging combined with (1) H MR spectroscopic imaging in the human prostate using a double tuned endorectal coil at 7T. Luttje MP; Italiaander MG; Arteaga de Castro CS; van der Kemp WJ; Luijten PR; van Vulpen M; van der Heide UA; Klomp DW Magn Reson Med; 2014 Dec; 72(6):1516-21. PubMed ID: 24357271 [TBL] [Abstract][Full Text] [Related]
6. Proton two-dimensional chemical shift imaging for evaluation of prostate cancer: external surface coil vs. endorectal surface coil. Kaji Y; Wada A; Imaoka I; Matsuo M; Terachi T; Kobashi Y; Sugimura K; Fujii M; Maruyama K; Takizawa O J Magn Reson Imaging; 2002 Dec; 16(6):697-706. PubMed ID: 12451583 [TBL] [Abstract][Full Text] [Related]
7. Validity of prostate-specific antigen as a tumour marker in men with prostate cancer managed by watchful-waiting: correlation with findings at serial endorectal magnetic resonance imaging and spectroscopic imaging. Coakley FV; Chen I; Qayyum A; Westphalen AC; Carroll PR; Hricak H; Chen MH; Kurhanewicz J BJU Int; 2007 Jan; 99(1):41-5. PubMed ID: 17227490 [TBL] [Abstract][Full Text] [Related]
8. Prostate cancer: metabolic response to cryosurgery as detected with 3D H-1 MR spectroscopic imaging. Kurhanewicz J; Vigneron DB; Hricak H; Parivar F; Nelson SJ; Shinohara K; Carroll PR Radiology; 1996 Aug; 200(2):489-96. PubMed ID: 8685346 [TBL] [Abstract][Full Text] [Related]
10. Two-dimensional spectroscopic imaging for pretreatment evaluation of prostate cancer: comparison with the step-section histology after radical prostatectomy. Weis J; Ahlström H; Hlavcak P; Häggman M; Ortiz-Nieto F; Bergman A Magn Reson Imaging; 2009 Jan; 27(1):87-93. PubMed ID: 18599244 [TBL] [Abstract][Full Text] [Related]
11. A phase and frequency alignment protocol for 1H MRSI data of the prostate. Wright AJ; Buydens LM; Heerschap A NMR Biomed; 2012 May; 25(5):755-65. PubMed ID: 21953616 [TBL] [Abstract][Full Text] [Related]
12. MR Spectroscopy in Prostate Cancer: New Algorithms to Optimize Metabolite Quantification. Bellomo G; Marcocci F; Bianchini D; Mezzenga E; D'Errico V; Menghi E; Zannoli R; Sarnelli A PLoS One; 2016; 11(11):e0165730. PubMed ID: 27832096 [TBL] [Abstract][Full Text] [Related]
13. [Spectroscopic imaging (1H-2D-CSI) of the prostate: sequence optimization and correlation with histopathological results]. Stanka M; Eltze E; Semjonow A; Sievert KD; Maier A; Pfleiderer B Rofo; 2000 Jul; 172(7):623-9. PubMed ID: 10962989 [TBL] [Abstract][Full Text] [Related]
14. Three-dimensional conformal external beam radiotherapy compared with permanent prostate implantation in low-risk prostate cancer based on endorectal magnetic resonance spectroscopy imaging and prostate-specific antigen level. Pickett B; Kurhanewicz J; Pouliot J; Weinberg V; Shinohara K; Coakley F; Roach M Int J Radiat Oncol Biol Phys; 2006 May; 65(1):65-72. PubMed ID: 16517094 [TBL] [Abstract][Full Text] [Related]
15. In vivo assessment of prostate cancer aggressiveness using magnetic resonance spectroscopic imaging at 3 T with an endorectal coil. Kobus T; Hambrock T; Hulsbergen-van de Kaa CA; Wright AJ; Barentsz JO; Heerschap A; Scheenen TW Eur Urol; 2011 Nov; 60(5):1074-80. PubMed ID: 21419565 [TBL] [Abstract][Full Text] [Related]
16. 2D JPRESS of human prostates using an endorectal receiver coil. Yue K; Marumoto A; Binesh N; Thomas MA Magn Reson Med; 2002 Jun; 47(6):1059-64. PubMed ID: 12111951 [TBL] [Abstract][Full Text] [Related]
18. [Multiparametric magnetic resonance imaging of the prostate - technique and clinical applications]. Franiel T Rofo; 2011 Jul; 183(7):607-17. PubMed ID: 21487980 [TBL] [Abstract][Full Text] [Related]
19. [MRI of prostate cancer using three different coil systems: image quality, tumor detection, and staging]. Beyersdorff D; Darsow U; Stephan C; Schnorr D; Loening S; Taupitz M Rofo; 2003 Jun; 175(6):799-805. PubMed ID: 12811693 [TBL] [Abstract][Full Text] [Related]
20. Clinical efficacy of proton magnetic resonance spectroscopy (1H-MRS) in the diagnosis of localized prostate cancer. Saito K; Kaminaga T; Muto S; Ide H; Nishio K; Kamiyama Y; Okada H; Terado Y; Furui S; Horie S Anticancer Res; 2008; 28(3B):1899-904. PubMed ID: 18630478 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]